Comment in

• Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.Doody RS. Alzheimers Dement. 2009 Mar; 5(2):133-6.
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." "Big Asks": what can be changed to increase and speed progress on Alzheimer's disease research and treatment? [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." "Big Asks": what can be changed to increase and speed progress on Alzheimer's disease research and treatment?Kukull WA. Alzheimers Dement. 2009 Mar; 5(2):137-9.
• Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients.Simpkins JW, Gatson JW, Wigginton JG. Alzheimers Dement. 2009 Mar; 5(2):143-6.
• Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke.Fillit H, Nash DT, Shineman D. Alzheimers Dement. 2009 Mar; 5(2):149-53.
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Subjective cognitive impairment as an antecedent of Alzheimer's dementia: policy import. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Subjective cognitive impairment as an antecedent of Alzheimer's dementia: policy import.Reisberg B, Shulman MB. Alzheimers Dement. 2009 Mar; 5(2):154-6.
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives.Cummings JL. Alzheimers Dement. 2009 Mar; 5(2):108-13.
• Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. [Alzheimers Dement. 2009]
  Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease.Gillette-Guyonnet S, Andrieu S, Dantoine T, Dartigues JF, Touchon J, Vellas B, MAPT Study Group. Alzheimers Dement. 2009 Mar; 5(2):114-21.
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges.Ringman JM, Grill J, Rodriguez-Agudelo Y, Chavez M, Xiong C. Alzheimers Dement. 2009 Mar; 5(2):166-71.
• Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease? [Alzheimers Dement. 2009]
  Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?Gauthier S, Poirier J. Alzheimers Dement. 2009 Mar; 5(2):147-8.
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Comments from abroad. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Comments from abroad.Korczyn AD. Alzheimers Dement. 2009 Mar; 5(2):157-8.
• Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Innovations in care that advance Alzheimer's disease drug development. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Innovations in care that advance Alzheimer's disease drug development.Foster NL, Andersen TC, Zamrini EY. Alzheimers Dement. 2009 Mar; 5(2):159-62.
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging.Schneider LS. Alzheimers Dement. 2009 Mar; 5(2):172-9.
• Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United States. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United States.Aisen PS. Alzheimers Dement. 2009 Mar; 5(2):125-7.
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal symposium 2008." The megacommunity approach to Alzheimer's disease. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II: Leon Thal symposium 2008." The megacommunity approach to Alzheimer's disease.Van Lee R, Meagher B, Fritz P, Penfield S. Alzheimers Dement. 2009 Mar; 5(2):163-5.
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging.Petersen RC. Alzheimers Dement. 2009 Mar; 5(2):105-7.
• Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.Petanceska S, Ryan L, Silverberg N, Buckholtz N. Alzheimers Dement. 2009 Mar; 5(2):130-2.
• Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.Ryan JM, Schneider G, Jacobsen JS. Alzheimers Dement. 2009 Mar; 5(2):140-2.
• Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." A national registry to identify a cohort for Alzheimer's disease prevention studies. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." A national registry to identify a cohort for Alzheimer's disease prevention studies.Sabbagh MN, Tariot PN. Alzheimers Dement. 2009 Mar; 5(2):128-9.
• Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors. [Alzheimers Dement. 2009]
  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors.Snyder PJ, Papp KV, Bartkowiak J, Jackson CE, Doody RS. Alzheimers Dement. 2009 Mar; 5(2):122-4.